Sexual dysfunction therapeutic approaches in patients with multiple sclerosis: a systematic review

• Published in: Neurological sciences 2023-03, Vol.44 (3), p.873-880
• Main Authors: Giannopapas, Vasileios, Kitsos, Dimitrios, Tsogka, Anthi, Tzartos, John S., Paraskevas, Georgios, Tsivgoulis, Georgios, Voumvourakis, Konstantinos, Giannopoulos, Sotirios, Bakalidou, Daphne
• Format: Article
• Language: English
• Subjects: Autonomic Nervous System in Clinical Practice; Botulinum toxin type A; Central nervous system; Cognitive ability; Demyelinating diseases; Demyelination; Electromyography; Exercise Therapy - methods; Feedback; Humans; Medicine; Medicine & Public Health; Multiple sclerosis; Multiple Sclerosis - complications; Multiple Sclerosis - psychology; Multiple Sclerosis - therapy; Neurology; Neuroradiology; Neurosciences; Neurosurgery; Pain - complications; Pelvis; Psychiatry; Review; Review Article; Sexual Dysfunction, Physiological - complications; Sexual Dysfunction, Physiological - therapy; Sildenafil Citrate; Spasticity; Systematic review
• ISSN: 1590-1874; 1590-3478
• DOI: 10.1007/s10072-022-06572-0

Objective Multiple sclerosis (MS) is the most common chronic inflammatory demyelinating disease of the central nervous system (CNS). The most common clinical manifestations of MS are spasticity, pain, vesico-urethral disorders, cognitive impairments, chronic fatigue and sexual dysfunction. This review aims to explore the possible therapeutic options for managing sexual dysfunction in people with MS (PwMS). Method A thorough search of the PubMed Medline database was performed. Records were limited to clinical studies published between 01/01/2010 up to 01/01/2022. The results were screened by the authors in pairs. Results The search identified 36 records. After screening, 9 records met the inclusion–exclusion criteria and were assessed. The pharmacological approaches investigated the effectiveness of sildenafil, tadalafil and onabotulinumtoxinA. Of the interventional studies the non-pharmacological investigated, the effectiveness of aquatic exercises, the application of pelvic floor exercises,the combination of pelvic floor exercises and mindfulness technique, the combination of pelvic floor exercises and electro muscular stimulation with electromyograph biofeedback, the application of yoga techniques and the efficacy of assistive devices like the clitoral vacuum suction device and the vibration device. Conclusion The management of sexual dysfunction in PwMS needs to be further investigated. A team of healthcare professionals should be involved in the management of SD in order to address not only the primary (MS-related) SD symptoms but the secondary and tertiary as well. The main limitations that were identified in the existing literature were related to MS disease features, sample characteristics and evaluation tools and batteries.